Ligand validation:4IBL

BEN: BENZAMIDINE

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
4IBL_BEN_H_301	94%	26%	0.08	0.977	1.26	1.71	-	2	0	0	100%	1
3TH2_BEN_H_1	94%	15%	0.077	0.977	1.15	2.58	-	5	0	0	100%	1
2AER_BEN_H_1001	85%	46%	0.09	0.954	1.47	0.64	2	-	1	0	100%	1
5PB1_BEN_D_508	84%	45%	0.096	0.957	1.17	0.97	1	1	0	0	100%	1
1KLI_BEN_H_300	4%	14%	0.225	0.589	2.35	1.55	5	1	0	0	100%	1
2BLW_BEN_A_1247	100%	23%	0.034	0.982	1.14	2.03	1	2	0	0	100%	1
4I8J_BEN_A_302	100%	47%	0.04	0.987	0.69	1.33	-	-	1	0	100%	0.57
2BLV_BEN_A_1247	100%	24%	0.036	0.982	1.12	1.97	1	2	0	0	100%	1
6B6P_BEN_A_302	100%	48%	0.034	0.979	1.18	0.85	1	1	0	0	100%	1
4I8K_BEN_A_252	100%	29%	0.048	0.993	0.81	1.99	-	4	1	0	100%	0.61

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.